NMPA Proposes Updates to Medical Device Classification Catalog
The NMPA Center for Medical Device Standardization Administration issued the “Notice on Soliciting Opinions on Adjustments of the Medical Device Classification Catalog” on August 7,
Register for Upcoming Webinar on DEC. 8 @ 11AM
2025 China NMPA Bluebook is here:
The NMPA Center for Medical Device Standardization Administration issued the “Notice on Soliciting Opinions on Adjustments of the Medical Device Classification Catalog” on August 7,

The NMPA granted innovation approval to Mevion Medical System’s proton therapy system and issued a review report on December 4, 2025. The published review reports

The NMPA granted innovation approval to Boston Scientific Neuromodulation’s DBS directional lead and issued a review report on November 6. The published review reports like

NMPA published the “Management for Temporary Importation and Use of Medical Devices Urgently Needed in Clinical Settings” on July 19, 2024. It green lights the

The NMPA granted innovation approvals to Intuitive Surgical’s bronchial navigation system and issued a review report. These published review reports serve as important references for

NMPA published twelve review reports in January 2024 for innovation devices. Among them are two imported devices. These published review reports serve as important references

The NMPA granted Innovation Approval to five medical devices in November 2023, including two additive manufactured devices: For an English copy of the “Tech Guide

The NMPA granted innovation approvals to Zap Surgical’s head and neck X-ray stereotactic radiosurgery system and issued a review report. It is the seventh imported

The NMPA issued the innovation approval review report for Varian’s Proton Therapy System. It is the seven imported innovative device approved by the NMPA so

NMPA granted innovation approval to Varian’s Proton Therapy System on November 1, 2023. What’s the Device This product consists of an accelerator subsystem and a

The NMPA granted innovative device status to 27 medical devices from July to September 2023: Cardiovascular Chemistry Dermatology Gastroenterology/Urology General hospital Neurology Oncology Ophthalmic Radiology

The NMPA reclassified certain neurosurgical, cardiac surgery, orthopedic, and hemodialysis, radiological equipment and devices and modified intended use for some with an announcement on August